Rivian (RIVN) Today: DA Davidson Lifts Price Target to $15 as CEO Pay Plan, AI Day and Q3 Momentum Dominate — Nov. 11, 2025

Rivian (RIVN) Stock Today, 15 Nov 2025: Q3 Revenue Jumps 78%, CEO’s New $4.6B Plan, VW Joint Venture Milestones — What It Means for 2026

Updated: Saturday, November 15, 2025 — Ticker: RIVN — Latest close (Fri):$15.11 (-7.9% on the day). The stock set a new 52‑week intraday high of $18.13 on Nov 11 before pulling back. [1]


Key takeaways

  • Momentum met volatility: After a post‑earnings surge to a 52‑week high on Nov 11, RIVN finished the week at $15.11, about 17% below Tuesday’s intraday peak. [2]
  • Fundamentals improved in Q3: Revenue rose 78% YoY to $1.558B; Software & Services revenue leapt to $416M, helping deliver Rivian’s first positive consolidated gross profit ($24M). [3]
  • Near‑term overhangs: Management narrowed 2025 delivery guidance to 41,500–43,500 and faces a U.S. EV policy reset after the $7,500 lease credit expired this fall. [4]
  • Strategic catalysts: VW–Rivian RV Tech JV begins winter testing this year; VW’s first model with the software stack (ID.Every1) is planned for 2027. [5]
  • Governance & signals: A new CEO pay package (up to $4.6B if aggressive targets are met) drew headlines; Form 4 filings show CEO share sales on Nov 11 under a 10b5‑1 plan. [6]

What moved RIVN in November

1) Q3 2025 results (Nov 4):
Rivian posted $1.558B in total revenue (+78% YoY) and delivered a $24M consolidated gross profit (vs. a $392M gross loss a year ago). The quarter’s standout was Software & Services: $416M revenue and $154M gross profit, largely reflecting revenue recognition tied to the Volkswagen JV’s software/electrical architecture work and higher remarketing and service activity. [7]

2) Guidance & policy backdrop:
On Oct 2 (ahead of earnings), Rivian narrowed its 2025 delivery outlook to 41,500–43,500 as the U.S. $7,500 EV lease credit expired on Oct 1 and new tariffs raised input costs—both viewed as demand and margin headwinds into year‑end. That caution framed how investors received the otherwise strong Q3 print. [8]

3) New CEO compensation plan (Nov 7):
The board approved a performance‑based package for CEO RJ Scaringe that could be worth up to $4.6B over a decade if ambitious operational and share‑price hurdles (e.g., tiered stock milestones) are hit. The move aims to align leadership with long‑term value creation as Rivian scales R2 and software. [9]

4) JV with Volkswagen — execution milestones (Nov 12):
RV Tech, the Rivian–Volkswagen software JV, said winter testing on VW reference vehicles begins by year‑end; VW’s compact ID.Every1 is slated to debut with the RV Tech stack in 2027. VW reiterated the partnership’s breadth (potentially reaching other drivetrains over time) and total investment commitment now described as $5.8B. [10]

5) Price action: 52‑week high, then a Friday fade:
RIVN closed $18.02 on Nov 11 (with $18.13 intraday 52‑week high), but fell to $15.11 by Friday. Part of Friday’s slide coincided with Form 4 disclosures showing the CEO sold 52,350 shares on Nov 11 under a pre‑set 10b5‑1 plan (a common, scheduled transaction type). [11]


The numbers that matter now

  • Revenue mix improves:
    • Automotive revenue:$1.142B (Q3)
    • Software & Services revenue:$416M (Q3), +324% YoY, $154M segment gross profit.
    • Consolidated gross profit:$24M (Q3). [12]
  • Liquidity runway:
    • Cash & equivalents:$4.44B
    • Short‑term investments:$2.65B
    • Total cash + ST investments:$7.09B (Sept 30, 2025).
    • Total liquidity (incl. ABL):$7.69B. [13]
  • Short interest: ~14% of float as of Oct 31, 2025—an element that can amplify both rallies and sell‑offs. [14]
  • Market cap context: ~$18.5B at Friday’s close. [15]

Strategic outlook: what to watch into 2026

R2 timing and capacity:
Rivian expects to start R2 production in the first half of 2026, with initial R2 assembly at the Normal, Illinois plant—lifted to ~215k annual capacity after recent upgrades—before Georgia comes online later. Successful, on‑time R2 launch is Rivian’s clearest path to scale, mix expansion, and fixed‑cost leverage. [16]

Software & JV monetization:
Q3 showed that Software & Services can be margin‑accretive as JV milestones are met. The winter testing phase and VW program road map (first launch in 2027) will be crucial for validating the cadence of this revenue stream. [17]

Policy environment:
The lease credit expiration and tariff regime shift near‑term demand/margin math industry‑wide. How Rivian offsets these (pricing, financing offers, fleet mix, operating costs) will drive Q4/Q1 unit economics as it heads toward R2. [18]

Investor events:
Management presented at the Barclays Global Automotive & Mobility Tech Conference this week—watch for any follow‑up commentary or post‑event notes that refine near‑term delivery/margin expectations. [19]


Street sentiment & price levels

  • Analyst moves this month:
    • DA Davidson: Target raised to $15 (Neutral) after Q3. [20]
    • Goldman Sachs: Target cut to $13 (Neutral). [21]
    • RBC Capital:Sector Perform, $14 target; maintains a cautious stance on liquidity and JV milestone timing. [22]
  • Technical context: New 52‑week high on Nov 11, followed by two sessions of profit‑taking into Friday’s close. If momentum resumes, traders will watch $18–18.50 (recent resistance). On the downside, low‑$14s (late‑October congestion) is the first support band many will eye. [23]

Near‑term scenarios (1–3 months)

This section is an analytical view, not investment advice.

  • Base case (Hold/Range trade): $13–$18.
    Q4 seasonality, policy headwinds and a still‑elevated short interest argue for swings around fundamentals that just turned the corner on gross profit. Sustained progress in Software & Services and clean JV updates would keep the upper half of the range in play. [24]
  • Bull case (Breakout retest): $20–$22.
    Requires confirmation that Q3 was a run‑rate step‑change (software milestones continue, R1 demand steady despite credit/tariff changes) and a supportive analyst revision cycle post‑events. [25]
  • Bear case (Policy/demand drag): $10–$12.
    If the credit expiration/tariffs dent order intake more than expected or JV timing slips, Street targets sitting near $13–$14 could cap rallies as the market leans defensively ahead of R2. [26]

Risks to monitor

  • Macro/policy: U.S. EV incentive changes and tariffs altering demand and BOM costs. [27]
  • Execution: R2 start‑of‑production timing; supplier readiness; Normal‑plant ramp to 215k capacity. [28]
  • JV milestones: Winter testing outcomes and 2026–27 program cadence at VW brands. [29]
  • Capital needs: While liquidity is solid (~$7.7B total liquidity), R2 launch and scaling remain cash‑intensive. [30]
  • Sentiment/governance: CEO package optics and scheduled insider sales can drive short‑term volatility despite 10b5‑1 planning. [31]

Bottom line

Rivian’s November scorecard mixes real operating progress (record revenue, first positive consolidated gross profit, fast‑growing software/services) with tighter guidance and a shifting policy backdrop. The VW partnership and R2 timing are the fulcrums for 2026. Into year‑end, expect news‑driven swings around the mid‑teens as the market sizes the durability of software revenue, the trajectory of R1 demand post‑credit, and the pace of JV milestones. [32]


Disclosure: This analysis is for informational purposes only and is not investment advice.

Rivian is focused on finding other sources of rare earth materials and magnets, says CEO RJ Scaringe

References

1. www.nasdaq.com, 2. www.nasdaq.com, 3. www.sec.gov, 4. www.reuters.com, 5. www.reuters.com, 6. www.reuters.com, 7. www.sec.gov, 8. www.reuters.com, 9. www.reuters.com, 10. www.reuters.com, 11. www.nasdaq.com, 12. www.sec.gov, 13. www.sec.gov, 14. finance.yahoo.com, 15. stockanalysis.com, 16. www.sec.gov, 17. www.sec.gov, 18. www.reuters.com, 19. www.nasdaq.com, 20. www.investing.com, 21. www.tipranks.com, 22. www.investing.com, 23. www.nasdaq.com, 24. www.sec.gov, 25. www.investing.com, 26. www.reuters.com, 27. www.reuters.com, 28. www.sec.gov, 29. www.reuters.com, 30. www.sec.gov, 31. www.reuters.com, 32. www.sec.gov

Stock Market Today

  • Insmed (INSM) Valuation Refined After Recent Price Surge: Fair Value $204.50
    November 15, 2025, 12:10 PM EST. Insmed has ridden a strong rally, with a three-month gain of 51%, a year-to-date return of 176%, and a 1-year total shareholder return around 191%. The latest analysis suggests a fair value of $204.50 per share, modestly above the current close of about $193.22, underpinning a bullish outlook built on Brinsupri's early sales momentum and potential rapid revenue growth in respiratory indications. Yet upside hinges on continued execution and faster commercial uptake; risks include regulatory delays and slower-than-expected adoption. Investors are encouraged to explore the full narrative and consider using stock screeners to compare Insmed against peers in a dynamic biotech landscape.
Saudi Economy Rockets: IMF Ups Forecast, 5% GDP Growth on the Table – and a Nobel Laureate Boosts Innovation
Previous Story

Wet Stock Management Market Update November 2025: Data‑Driven Fuel Inventory, Key Deals and 2030 Outlook

SoFi Technologies (SOFI) news today (Nov. 6, 2025): Stock wobbles as SoFi’s Galileo debuts Southwest debit‑rewards card; fresh fund flows and bullish commentary keep momentum in focus
Next Story

SoFi Stock Forecast: Crypto Pivot, Record Earnings and Volatile Highs as of November 15, 2025

Go toTop